Group Compassionate Mind Training for Adults Experiencing the Menopause Transition
NCT ID: NCT06462157
Last Updated: 2024-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-06-20
2026-10-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to find out how practical and suitable group CMT is for improving the wellbeing of adults experiencing the menopause, and what their views are on the therapy and taking part in the study. To measure the aims, we will look at the ease of recruiting people to the study, whether they are happy to be randomly allocated to receive the therapy or not, whether they stay in the study, the number of completed questionnaires and feedback from participants. It will also look at whether there have been any changes in different domains e.g. anxiety and self-compassion. This will be done through a variety of quantitative and qualitative outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Internet- and Mobile-based Group Treatment in Menopausal Women
NCT03948269
Mindfulness Intervention for Maltreatment-Related Cognitive Decline
NCT07066800
Mindfulness-based Lifestyle Modification Programme for Caregivers of People With Neurological Disorders
NCT07342140
Examine the Effects of Mindfulness in Woman With a History of Child Adversity
NCT05255380
Effects of Mindfulness Training on the Emotional Experience and (Non-) Acceptance of Emotions in Adolescents
NCT04159272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Online CMT groups
Online Compassionate Mind Training
Compassionate Mind Training
Participants will attend 6 x 90-minute online CMT sessions. CMT is delivered by combining taught information, exercises, and practices. It is effective, so the aim is to explore its use with menopausal women.
Control Group
Treatment as usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compassionate Mind Training
Participants will attend 6 x 90-minute online CMT sessions. CMT is delivered by combining taught information, exercises, and practices. It is effective, so the aim is to explore its use with menopausal women.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who are experiencing symptoms of the menopause or peri-menopause; which is naturally occurring. This is identified through the STRAW criteria. Individuals have to answer Yes on at least one of the STRAW screening questions to ensure women are in the perimenopause or menopausal period.
* Substantial English verbal communication and comprehension skills
* Capacity to consent
* Confident in using video conferencing applications (MsTeams)
* Willingness to take part in a post-intervention interview about their experience.
* PHQ-9 score 5-19 (mild to moderate clinical cut offs)
* GAD-7 score 5-15 (mild to moderate clinical cut offs)
Exclusion Criteria
* People currently receiving any form of psychology intervention.
* Transgender females who are biologically male
* More than 5 years post menopause.
* PHQ-9 score greater or equal to 20 (severe clinical cut off)
* GAD-7 score greater or equal to 15 (severe clinical cut off)
40 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aimee Spector
Role: PRINCIPAL_INVESTIGATOR
UCL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College London
London, County, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26701/001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.